140 related articles for article (PubMed ID: 35831833)
1. High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma.
Chen C; Chen S; Luo G; Wang L; Zeng C; Przybylski GK; Li Y
Biomark Res; 2022 Jul; 10(1):46. PubMed ID: 35831833
[TBL] [Abstract][Full Text] [Related]
2. TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma.
Chen C; Chen Z; Huang L; Zhou L; Zhu L; Liu S; Luo G; Li W; Zeng C; Li Y
Cancer Cell Int; 2021 Sep; 21(1):490. PubMed ID: 34526012
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells.
Iżykowska K; Rassek K; Żurawek M; Nowicka K; Paczkowska J; Ziółkowska-Suchanek I; Podralska M; Dzikiewicz-Krawczyk A; Joks M; Olek-Hrab K; Giefing M; Przybylski GK
J Cell Mol Med; 2020 Sep; 24(18):10970-10977. PubMed ID: 32794659
[TBL] [Abstract][Full Text] [Related]
4. T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
[TBL] [Abstract][Full Text] [Related]
5. TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
Chen C; Zhou L; Zhu L; Luo G; Wang L; Zeng C; Zhou H; Li Y
Cancer Med; 2023 Feb; 12(4):3952-3961. PubMed ID: 36056685
[TBL] [Abstract][Full Text] [Related]
6.
Rassek K; Iżykowska K; Żurawek M; Pieniawska M; Nowicka K; Zhao X; Przybylski GK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834942
[TBL] [Abstract][Full Text] [Related]
7. Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.
Sui S; Li Z; Tan J; Wang L; Luo G; Zeng C; Luo OJ; Chen C; Li Y
J Oncol; 2022; 2022():2787426. PubMed ID: 35983088
[TBL] [Abstract][Full Text] [Related]
8. Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome.
Huang X; Chen C; Zhong M; Geng S; Zhao Y; Li M; Deng C; Zeng L; Wu P; Lu Z; Weng J; Du X; Li Y
Biomark Res; 2021 Jun; 9(1):46. PubMed ID: 34112264
[TBL] [Abstract][Full Text] [Related]
9. Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell Lymphoma Patients.
Chen C; Huang L; Chen Z; Ou Q; Liu S; Jiang X; Chen F; Wei X; Guo H; Shao Y; Zeng C; Li Y; Li W
Adv Biol (Weinh); 2023 Dec; 7(12):e2300042. PubMed ID: 37658484
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases.
Avery PR; Burton J; Bromberek JL; Seelig DM; Elmslie R; Correa S; Ehrhart EJ; Morley PS; Avery AC
J Vet Intern Med; 2014; 28(2):538-46. PubMed ID: 24495161
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometry.
Harris LJ; Rout ED; Labadie JD; Avery PR; Fernandez M; Yoshimoto J; Avery AC
Vet Comp Oncol; 2020 Sep; 18(3):416-427. PubMed ID: 31951040
[TBL] [Abstract][Full Text] [Related]
12. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.
Niederwieser D; Grassegger A; Auböck J; Herold M; Nachbaur D; Rosenmayr A; Gächter A; Nussbaumer W; Gaggl S; Ritter M
Blood; 1993 Apr; 81(8):2200-8. PubMed ID: 8471780
[TBL] [Abstract][Full Text] [Related]
13. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Foss HD; Anagnostopoulos I; Herbst H; Grebe M; Ziemann K; Hummel M; Stein H
Blood; 1995 May; 85(10):2862-9. PubMed ID: 7742548
[TBL] [Abstract][Full Text] [Related]
14. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
[TBL] [Abstract][Full Text] [Related]
15. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of centrosomal protein 55 in T-cell lymphoma.
Xu Y; Zhou X; Li Y; Zhang Y; Wang X
J Cancer Res Ther; 2018 Jan; 14(1):94-98. PubMed ID: 29516967
[TBL] [Abstract][Full Text] [Related]
17. Treatment of T cell lymphoma in dogs.
Moore AS
Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Blaxill J; Buzzacott P; Finlay J
Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
[TBL] [Abstract][Full Text] [Related]
19. Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.
Iżykowska K; Przybylski GK; Gand C; Braun FC; Grabarczyk P; Kuss AW; Olek-Hrab K; Bastidas Torres AN; Vermeer MH; Zoutman WH; Tensen CP; Schmidt CA
Oncotarget; 2017 Jun; 8(24):39627-39639. PubMed ID: 28489605
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
